Needham & Company Reiterates Buy Rating, $57 Price Target on Harmony Biosciences Holdings Inc. (HRMY)
Go back to Needham & Company Reiterates Buy Rating, $57 Price Target on Harmony Biosciences Holdings Inc. (HRMY)| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 39.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.77 | 52 Week High | $1.35 | |||
| Open | $39.77 | 52 Week Low | $0.10 | |||
| Day High | $39.77 | P/E | N/A | |||
| Day Low | $39.77 | EPS | $0.00 | |||
| Volume | 1,309 | |||||
